Literature DB >> 18625903

Put your chips on transcriptomics.

Gerald W Dorn, Scot J Matkovich.   

Abstract

Mesh：

Substances：

Year:  2008        PMID： 18625903     DOI： 10.1161/CIRCULATIONAHA.108.789933

Source DB:  PubMed          Journal:  Circulation        ISSN： 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  10 in total

Review 1.  Therapeutic potential of microRNAs in heart failure.

Authors:  Gerald W Dorn
Journal:  Curr Cardiol Rep       Date:  2010-05       Impact factor: 2.931

Review 2.  microRNAs in heart disease: putative novel therapeutic targets?

Authors:  Gianluigi Condorelli; Michael V G Latronico; Gerald W Dorn
Journal:  Eur Heart J       Date:  2010-01-29       Impact factor: 29.983

3.  Deep mRNA sequencing for in vivo functional analysis of cardiac transcriptional regulators: application to Galphaq.

Authors:  Scot J Matkovich; Yan Zhang; Derek J Van Booven; Gerald W Dorn
Journal:  Circ Res       Date:  2010-04-01       Impact factor: 17.367

Review 4.  MicroRNAs--regulators of signaling networks in dilated cardiomyopathy.

Authors:  Sathyamangla V Naga Prasad; Sadashiva S Karnik
Journal:  J Cardiovasc Transl Res       Date:  2010-05-01       Impact factor: 4.132

5.  Reciprocal regulation of myocardial microRNAs and messenger RNA in human cardiomyopathy and reversal of the microRNA signature by biomechanical support.

Authors:  Scot J Matkovich; Derek J Van Booven; Keith A Youker; Guillermo Torre-Amione; Abhinav Diwan; William H Eschenbacher; Lisa E Dorn; Mark A Watson; Kenneth B Margulies; Gerald W Dorn
Journal:  Circulation       Date:  2009-02-23       Impact factor: 29.690

6.  Distinct epigenomic features in end-stage failing human hearts.

Authors:  Mehregan Movassagh; Mun-Kit Choy; David A Knowles; Lina Cordeddu; Syed Haider; Thomas Down; Lee Siggens; Ana Vujic; Ilenia Simeoni; Chris Penkett; Martin Goddard; Pietro Lio; Martin R Bennett; Roger S-Y Foo
Journal:  Circulation       Date:  2011-10-24       Impact factor: 29.690

7.  MicroRNA Expression in Myocardial Tissue and Plasma of Patients with End-Stage Heart Failure during LVAD Support: Comparison of Continuous and Pulsatile Devices.

Authors:  Sjoukje I Lok; Nicolaas de Jonge; Joyce van Kuik; Ankie J P van Geffen; Manon M H Huibers; Petra van der Weide; Erica Siera; Bjorn Winkens; Pieter A Doevendans; Roel A de Weger; Paula A da Costa Martins
Journal:  PLoS One       Date:  2015-10-02       Impact factor: 3.240

Review 8.  Physical activity in the prevention of human diseases: role of epigenetic modifications.

Authors:  Elisa Grazioli; Ivan Dimauro; Neri Mercatelli; Guan Wang; Yannis Pitsiladis; Luigi Di Luigi; Daniela Caporossi
Journal:  BMC Genomics       Date:  2017-11-14       Impact factor: 3.969

Review 9.  Research Progress on Epigenetics of Diabetic Cardiomyopathy in Type 2 Diabetes.

Authors:  Jianxin Deng; Yunxiu Liao; Jianpin Liu; Wenjuan Liu; Dewen Yan
Journal:  Front Cell Dev Biol       Date:  2021-12-24

10.  Differential DNA methylation correlates with differential expression of angiogenic factors in human heart failure.

Authors:  Mehregan Movassagh; Mun-Kit Choy; Martin Goddard; Martin R Bennett; Thomas A Down; Roger S-Y Foo
Journal:  PLoS One       Date:  2010-01-13       Impact factor: 3.240
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.